ArticleNPJ breast cancer2022

In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence.

Megan C Madonna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.